Loading clinical trials...

COMPLETED

Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial Infarction

NCT04309994•University Hospital, Basel, Switzerland

Summary

The goal of this study is to compare the two cardioplegia solutions (blood cardioplegia by means of MPS ® vs. Cardioplexol ®) regarding perioperative outcome and with special attention to cardiac markers in patients with a recent heart attack.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients who underwent a CABG using MPS® or Cardioplexol ®
•Heart attack less than 7 days before surgery

Exclusion Criteria

•use of other cardioplegia solution than Cardioplexol ® or MPS®
•other inventions than CABG
•explicit will of the patient that his data may not be used
•denied general consent

Locations (1)

Cardiac Surgery Clinic University Hospital Basel

Basel, Switzerland

Key Dates

Start Date

February 1, 2010

Primary Completion Date

January 1, 2020

Completion Date

January 1, 2020

Last Updated

March 17, 2020

Enrollment

307

ACTUAL participants

Conditions

Heart AttackCardioplegia Solution Adverse ReactionCoronary Artery Bypass Grafting (CABG)

Interventions

Myocardial protection system (MPS)

OTHER

Cardioplexol

OTHER

Effect of Nurse-Led Education and Tele-Interventions on Reducing Surgical Site Infections in Patients After Coronary Artery Bypass Surgery: a Clinical Trial

NCT06586749

Surgical Site InfectionCoronary Artery Bypass Grafting (CABG)

View study

NOT_YET_RECRUITINGNA

Improving the Quality of Coronary Artery Bypass Grafting

NCT07377149

Coronary Artery Bypass Grafting (CABG)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 17, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial Infarction

Inclusion Criteria

Exclusion Criteria

Effect of Nurse-Led Education and Tele-Interventions on Reducing Surgical Site Infections in Patients After Coronary Artery Bypass Surgery: a Clinical Trial

Improving the Quality of Coronary Artery Bypass Grafting

Immunomodulatory Effects of PCSK9 Inhibition

Home Telemonitoring In Patients After Myocardial Infarction

CV Wizard: Does a Clinical Decision Support Tool Improve CVD Risk Factor Control in Safety Net Clinics?

Stress Management and Resiliency Training Following Acute Myocardial Infarction